Alexandre Ismail

v:escapeXmlAttribut(profileItem.fullName)

Structural Biology & Business Development at BioQuanta

Paris, France

Bienvenue sur l'aperçu du profil de Alexandre Ismail

Inscrivez-vous pour voir son profil complet

Votre prénom est obligatoirev
Votre nom est obligatoirev
vAdresse e-mail invalide
vVotre mot de passe doit contenir au moins 3 caractères

Viadeo, le réseau de tous les professionnels

Votre réseauRetrouvez vos contacts et rencontrez des professionnels.

Votre carrièreFaites-vous connaître et valorisez votre expertise.

Votre businessTrouvez les bons contacts et développez votre activité.

Son parcours

  • Aujourd'hui
    2014
    2010

    Biologie Structurale et Systemique: les chemokines

    11-50 employés

  • Aujourd'hui
    2014
    2009

    Bus.Dev: applying virtual screening to REACH toxicity characterization

    11-50 employés

  • Master en Biologie Systemique et Synthetique
  • , Villejuif

    Sup'Biotech

    Biotechnology - MA
  • Aujourd'hui
    2009
    2007

    Molecular Modeling Consultant

    Avatar Biotechnologies

    Predicting stability and shape of novel modifications to existing therapeutic proteins.

    Mutagenesis sites were rationally selected, saving hundreds of dollars per construct that no longer needed to be screened for activity in the lab.

    A detailed structural analysis was also used as technical documentation in the successful support of a patent application for the client's experimental methods.

    A portfolio of potential targets for modification among currently marketed therapeutic proteins was also generated.
  • , New York City

    Hunter College CUNY

    Biochemistry - BA
    Biochemistry

Inscrivez-vous pour consulter le profil complet de Alexandre Ismail

S'INSCRIRE

Ses centres d'intérêt

structural biology new methods of modeling biological systems New Kind of Science NKS protein structure molecular structure road biking fencing snorkeling and diving

Sa présentation

Dear colleagues,

I'm excited about bringing you some news from our corner of the industry!

Here at BioQuanta, we have developed a virtual screening system to identify the toxicity potential of a molecule based on comparison to 3-dimensional pharmacophore libraries of compounds known to be toxic.

Our most recent development is an interactive version of our virtual screening report. The results are now presented in an HTML format incorporating interactive 3D visualization, searchable and sortable results, as well as links to external databases for additional information.

From REACH to R&D - take a second look at your molecules with our pharmacophore screening.

The new demo version is available at the BioQuanta HTVS link.
BioQuanta HTVS
http://bioquanta.com/multidip/demo/

Son activité sur Viadeo

Ses derniers contacts
Alexandru Vilau
Josselin Caradec
Julien Conti
Mélinda LE BRETON

Ceux qui ont consulté ce profil ont aussi vu :